We Know Bioanalysis.

At Lablytica, we offer bioanalytical services to quantify your drug or biomarker in a variety of biological matrices. All method development, validation, and analysis activities at Lablytica utilize fully qualified instruments at our facility in Uppsala, Sweden. Lablytica is fully compliant with OECD GLP and performs method validation and PK sample analysis for preclinical and clinical studies according to ICH M10.

Why Lablytica?

Our team consists of dedicated analytical chemists who deliver fast, high-quality results. We specialize in bioanalysis of both large and small molecules, as well as biomarkers, during the preclinical and clinical stages of your drug development. We also offer GLP-compliant dose formulation analysis to cover all your analytical needs.

Lablytica’s facilities are located near Sweden’s largest international airport, allowing us to quickly receive samples from anywhere in the world. We have experience working with test sites world-wide and can tailor our reports to meet your needs. We are part of the Swedish accreditation body’s OECD GLP compliance and inspection program.

Lablytica is a member of the CTR group; a group of complementary life science companies offering full-service phase I – III clinical study conduct in Sweden and The Netherlands, regulatory advice, DMPK/MIST and toxicology support, GLP-certified bioanalysis, Quality Assurance and overall project strategy planning in the life science sector. 

Lablytica is part of the Swedish OECD GLP program. The last OECD GLP inspection of Lablytica was performed in May 2024.

Lablytica is regularly inspected by SWEDAC, the regulatory body performing OECD GLP inspection of laboratories in Sweden.

Lablytica is represented in the core group of the European Bioanalysis Forum (EBF).